Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injection of Plasma Rich in Growth Factor (PRGF) in infertile women with poor ovarian response
IRCT20240815062771N3Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of PRGF-Endoret in poor ovarian response (POR) and infertility, sponsored by Tehran University of Medical Sciences. Started Feb 2025; status: completed.
02
Drugs
PRGF-Endoret
03
Conditions
poor ovarian response (POR)infertility
Beyond the preview
Go deeper on IRCT20240815062771N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240815062771N3.